Find Bykomcyin manufacturers, exporters & distributors on PharmaCompass

Bykomcyin

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DIGITAL CONTENT

1 NEWS #PharmaBuzz

media
1 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Framycetin (sulfate), Fradiomycin b (sulfate); neomycin b (sulfate), Neomycin sulfate, 4146-30-9, Bcp28374, Neomycin sulfate; neomycin sulphate b

Molecular Formula

C₂₃H₅₂N₆O₂₅S₃

Molecular Weight

908.9 g/mol

InChI Key

KWBUARAINLGYMG-UHFFFAOYSA-N

Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis.

1 2D Structure

Bykomcyin

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol;sulfuric acid

2.1.2 InChI

InChI=1S/C23H46N6O13.3H2O4S/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22;3*1-5(2,3)4/h5-23,30-36H,1-4,24-29H2;3*(H2,1,2,3,4)

2.1.3 InChI Key

KWBUARAINLGYMG-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O

2.2 Synonyms

2.2.1 MeSH Synonyms

1. Fradiomycin Sulfate

2. Neomycin

3. Neomycin Palmitate

4. Neomycin Sulfate

2.2.2 Depositor-Supplied Synonyms

1. Framycetin (sulfate)

2. Fradiomycin B (sulfate); Neomycin B (sulfate)

3. Neomycin Sulfate

4. 4146-30-9

5. Bcp28374

6. Neomycin Sulfate; Neomycin Sulphate B

2.3 Create Date

2009-08-08

3 Chemical and Physical Properties

Molecular Formula	C₂₃H₅₂N₆O₂₅S₃
Molecular Weight	908.9 g/mol
Hydrogen Bond Donor Count	19
Hydrogen Bond Acceptor Count	31
Rotatable Bond Count	9
Exact Mass	908.21442469 g/mol
Monoisotopic Mass	908.21442469 g/mol
Topological Polar Surface Area	602 Å²
Heavy Atom Count	57
Formal Charge	0
Complexity	953
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	19
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	4

4 Drug and Medication Information

4.1 Drug Information

1 of 20
Drug Name	NEO-SYNALAR
Active Ingredient	FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE
Company	MEDIMETRIKS PHARMS (Application Number: A060700)

2 of 20
Drug Name	NEOMYCIN AND POLYMYXIN B SULFATE
Active Ingredient	NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Company	WATSON LABS (Application Number: A062664); X GEN PHARMS (Application Number: A065106); X GEN PHARMS (Application Number: A065108)

3 of 20
Drug Name	NEOSPORIN G.U. IRRIGANT
Active Ingredient	NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Company	MONARCH PHARMS (Application Number: A060707)

4 of 20
Drug Name	NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC
Active Ingredient	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Company	AKORN (Application Number: A065088); BAUSCH AND LOMB (Application Number: A064064); PERRIGO CO TENNESSEE (Application Number: A060764)

5 of 20
Drug Name	NEOSPORIN
Active Ingredient	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Company	CASPER PHARMA LLC (Application Number: N050417)

6 of 20
Drug Name	DEXASPORIN
Active Ingredient	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Company	BAUSCH AND LOMB (Application Number: A064135)

7 of 20
Drug Name	MAXITROL
Active Ingredient	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Company	NOVARTIS PHARMS CORP (Application Number: N050023); NOVARTIS PHARMS CORP (Application Number: N050065); SANDOZ INC (Application Number: A062341)

8 of 20
Drug Name	NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE
Active Ingredient	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Company	BAUSCH AND LOMB (Application Number: A064063); PERRIGO CO TENNESSEE (Application Number: A062938)

9 of 20
Drug Name	NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN
Active Ingredient	GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Company	AMRING PHARMS (Application Number: A065187); BAUSCH AND LOMB (Application Number: A064047)

10 of 20
Drug Name	NEOSPORIN
Active Ingredient	GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Company	MONARCH PHARMS (Application Number: A060582)

11 of 20
Drug Name	CORTISPORIN
Active Ingredient	HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Company	MONARCH PHARMS (Application Number: N050218)

12 of 20
Drug Name	CASPORYN HC
Active Ingredient	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Company	CASPER PHARMA LLC (Application Number: N060613)

13 of 20
Drug Name	CORTISPORIN
Active Ingredient	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Company	MONARCH PHARMS (Application Number: N050479)

14 of 20
Drug Name	NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
Active Ingredient	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Company	AMRING PHARMS (Application Number: A065216); AMRING PHARMS (Application Number: A065219); BAUSCH AND LOMB (Application Number: A064053); SANDOZ INC (Application Number: A062423); SANDOZ INC (Application Number: A062488); SANDOZ INC (Application Number: A062874)

15 of 20
Drug Name	OTICAIR
Active Ingredient	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Company	BAUSCH AND LOMB (Application Number: A064065)

16 of 20
Drug Name	BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE
Active Ingredient	BACITRACIN ZINC; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Company	PERRIGO CO TENNESSEE (Application Number: A062166)

17 of 20
Drug Name	CORTISPORIN
Active Ingredient	BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Company	MONARCH PHARMS (Application Number: N050168)

18 of 20
Drug Name	NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE
Active Ingredient	BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Company	AKORN (Application Number: A065213); BAUSCH AND LOMB (Application Number: A064068)

19 of 20
Drug Name	COLY-MYCIN S
Active Ingredient	COLISTIN SULFATE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; THONZONIUM BROMIDE
Company	ENDO PHARMS INC (Application Number: N050356)

20 of 20
Drug Name	NEOMYCIN SULFATE
Active Ingredient	NEOMYCIN SULFATE
Company	BRECKENRIDGE PHARM (Application Number: A065468); LANNETT CO INC (Application Number: A204435); TEVA (Application Number: A060304); X GEN PHARMS (Application Number: A065220)

5 Pharmacology and Biochemistry

5.1 MeSH Pharmacological Classification

Anti-Bacterial Agents

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)

Protein Synthesis Inhibitors

Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)

Digital Content

Create Content with PharmaCompass, ask us